Cargando…
Cancer metabolism challenges genomic instability and clonal evolution as therapeutic targets
Although cancer precision medicine has improved diagnosis and therapy, refractory cancers such as pancreatic cancer remain to be challenging targets. Clinical sequencing has identified the significant alterations in driver genes and traced their clonal evolutions. Recent studies indicated that the t...
Autores principales: | Takeda, Yu, Chijimatsu, Ryota, Ofusa, Ken, Kobayashi, Shogo, Doki, Yuichiro, Eguchi, Hidetoshi, Ishii, Hideshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990295/ https://www.ncbi.nlm.nih.gov/pubmed/35112433 http://dx.doi.org/10.1111/cas.15279 |
Ejemplares similares
-
Impact of One-Carbon Metabolism-Driving Epitranscriptome as a Therapeutic Target for Gastrointestinal Cancer
por: Takeda, Yu, et al.
Publicado: (2021) -
Epithelial Cell Transformation and Senescence as Indicators of Genome Aging: Current Advances and Unanswered Questions
por: Kitakaze, Masatoshi, et al.
Publicado: (2021) -
N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma
por: Tatekawa, Shotaro, et al.
Publicado: (2022) -
Methylosystem for Cancer Sieging Strategy
por: Tatekawa, Shotaro, et al.
Publicado: (2021) -
State-of-the-Art Technology of Model Organisms for Current Human Medicine
por: Konno, Masamitsu, et al.
Publicado: (2020)